HIP JOINT REPLACEMENT FOR IDIOPATHIC OSTEOARTHRITIS AGGREGATES IN FAMILIES
HIP JOINT REPLACEMENT FOR IDIOPATHIC OSTEOARTHRITIS AGGREGATES IN FAMILIES
批准号:
7600991
负责人:
Matthew L Warman
金额:
$0.51万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2008-07-31
关键词:
AffectAgeAmericanArthroplastyBiochemicalBone and Cartilage FundingComputer Retrieval of Information on Scientific Projects DatabaseControl GroupsDegenerative polyarthritisDiagnosisDiseaseFailureFamilyFamily history ofFundingGeneticGrantHip JointHip OsteoarthritisHip region structureHistologicHormonalInstitutionJointsKnee OsteoarthritisKnee jointMechanicsMolecularObesityPatientsPrevalenceReplacement ArthroplastyResearchResearch PersonnelResourcesRheumatologySiblingsSourceSpousesStagingSusceptibility GeneSynovial CellTotal Hip ReplacementUnited States National Institutes of Healthcohortcollegeknee replacement arthroplastyprobandsex
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Osteoarthritis (OA) is a multifactorial disease. Environmental, hormonal, obesity, mechanical, and genetic factors have been implicated in its onset and progression. OA is clinically heterogeneious because it can affect large or small joints, can be monoarticular or polyartiuclar, and can be associated with subtle or obvious physical and/or radiographic changes. OA is also heterogeneous with respect to the histologic, biochemical, and molecular changes observed in bone, cartilage, and synovial cells and matrices. In order to determine whether there is a genetic component to hip or knee joint failure due to OA, we invited patients (probands) undergoing hip or knee arthroplasty for management of idiopathic OA to provide detailed family histories regarding the prevalence of idiopathic OA requiring joint replacement in their siblings. We also invited their spouses to provide detailed family histories about their siblings to serve as a control group. In the probands, we confirmed the diagnosis of idiopathic OA using American College of Rheumatology criteria. The cohorts included the siblings of 635 probands undergoing total hip replacement, the siblings of 486 probands undergoing total knee replacement, and the siblings of 787 spouses. We compared the prevalence of arthroplasty for idiopathic OA among the siblings of the probands with that among the siblings of the spouses. Familial aggregation for hip arthroplasty, but not for knee arthroplasty, was observed after controlling for age and sex, suggesting a genetic contribution to end-stage hip OA but not to end-stage knee OA. We conclude that attempts to identify genes that predispose to idiopathic OA resulting in joint failure are more likely to be successful in patients with hip OA than in those with knee OA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Conditional mouse models with dominant negative Osteogenesis Imperfecta
-
批准号:10646852
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2023
-
负责人:Matthew L Warman
-
依托单位:
Skeletal and non-skeletal roles for osteocalcin
-
批准号:10417887
-
项目类别:
-
资助金额:$39.81万
-
财政年份:2022
-
负责人:Matthew L Warman
-
依托单位:
Skeletal and non-skeletal roles for osteocalcin
-
批准号:10595042
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2022
-
负责人:Matthew L Warman
-
依托单位:
Neurobehavioral phenotypes of mouse models of Osteogenesis Imperfecta
-
批准号:10416072
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2021
-
负责人:Matthew L Warman
-
依托单位:
Neurobehavioral phenotypes of mouse models of Osteogenesis Imperfecta
-
批准号:10303525
-
项目类别:
-
资助金额:$19.47万
-
财政年份:2021
-
负责人:Matthew L Warman
-
依托单位:
The Efficacy of combination therapy in Osteogenesis Imperfecta
-
批准号:8900679
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2015
-
负责人:Matthew L Warman
-
依托单位:
Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study
-
批准号:8720467
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2014
-
负责人:Matthew L Warman
-
依托单位:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
-
批准号:9052710
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2014
-
负责人:Matthew L Warman
-
依托单位:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
-
批准号:8830919
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2014
-
负责人:Matthew L Warman
-
依托单位:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
-
批准号:9245631
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2014
-
负责人:Matthew L Warman
-
依托单位:
Does increasing bone mass also increase bone strength in mouse models of OI?
-
批准号:8232602
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2011
-
负责人:Matthew L Warman
-
依托单位:
Does increasing bone mass also increase bone strength in mouse models of OI?
-
批准号:8334034
-
项目类别:
-
资助金额:$15.12万
-
财政年份:2011
-
负责人:Matthew L Warman
-
依托单位:
HIP JOINT REPLACEMENT FOR IDIOPATHIC OSTEOARTHRITIS AGGREGATES IN FAMILIES
-
批准号:7420644
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2006
-
负责人:Matthew L Warman
-
依托单位:
PAMIDRONATE IN CHILDREN WITH MODERATE TO SEVERE OSTEOGENESIS IMPERFECTA
-
批准号:7202750
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2005
-
负责人:Matthew L Warman
-
依托单位:
Pamidronate in children with moderate to severe osteogenesis imperfecta
-
批准号:6974948
-
项目类别:
-
资助金额:$3.23万
-
财政年份:2004
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:7119282
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:6913515
-
项目类别:
-
资助金额:$41.32万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:6764219
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:6674568
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:7268803
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: